Why verification matters more than ever
The GLP-1 telehealth market exploded in 2024–2025 and brought both legitimate providers and bad actors. Since September 2025, the FDA has issued over 85 warning letters to telehealth companies for misleading claims about compounded GLP-1 products — and in February 2026, HHS referred at least one major platform to the Department of Justice. FDA Commissioner Makary called it "a new era" of enforcement.
This doesn't mean all telehealth GLP-1 providers are unsafe. It means you need to verify before you trust. Here are the five checks that take less than 15 minutes and can protect you from substandard care.
Check 1: State medical licensing
Every telehealth provider prescribing GLP-1 medications must employ or contract with physicians or nurse practitioners licensed in the state where you live. You can verify this by asking the provider which clinicians will review your case, then checking their license status on your state's medical board website. If the provider won't name their clinicians or their licenses can't be verified, that's a disqualifying red flag.
Check 2: Compounding pharmacy credentials
If the provider offers compounded GLP-1 medications, ask which pharmacy compounds them and whether it's a 503A (state-licensed) or 503B (FDA-registered) facility. A 503B outsourcing facility is the gold standard — FDA-inspected, follows cGMP, and tests every batch. You can verify 503B registration on the FDA's Outsourcing Facility Registration database. If the provider can't or won't answer this question, that's a significant red flag.
Check 3: LegitScript certification
LegitScript is an independent certification service that verifies telehealth platforms comply with applicable pharmacy laws and regulations. Certification involves verification of pharmacy licensing, prescriber credentials, controlled substance protocols, and privacy practices. You can check any provider's LegitScript status at legitscript.com. Not every legitimate provider has LegitScript certification (it's voluntary and costs money), but having it is a strong positive signal.
Check 4: FDA warning letter search
The FDA publishes all warning letters on its website. Search for the provider's company name in the FDA Warning Letters database. A warning letter doesn't necessarily mean the provider is unsafe — some letters address marketing language rather than patient safety — but it does mean the FDA identified compliance issues that warrant your attention. Read the specific violations cited before making a judgment.
Check 5: Pricing transparency
Legitimate providers publish clear, all-in pricing. They don't hide membership fees, escalate pricing at higher doses without disclosure, or lock you into auto-renewal contracts buried in fine print. If you can't determine your total monthly cost at maintenance dose within 5 minutes on their website, that's a yellow flag.
Bonus: check for a medical intake
Any provider that offers GLP-1 medication without a medical intake (health history questionnaire, medication review, contraindication screening) is operating below standard of care. GLP-1 medications have absolute contraindications (medullary thyroid cancer history, MEN type 2, pregnancy) that must be screened before prescribing. If you can order GLP-1 medication the same way you order supplements — no medical questions asked — walk away.